Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Not Confirmed
Not Confirmed
01-03 June, 2026
CPhI North AmericaCPhI North America
Not Confirmed
Not Confirmed
02-04 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Industry Trade Show
Not Confirmed
01-03 June, 2026
CPhI North AmericaCPhI North America
Industry Trade Show
Not Confirmed
02-04 June, 2026
Digital content

15 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/15/2930675/0/en/CV6-Therapeutics-Announces-Initiation-of-Patient-Dosing-in-Phase-1a-Clinical-Trial-Evaluating-the-Investigational-First-In-Class-Specific-dUTPase-Inhibitor-CV6-168.html
ABOUT THIS PAGE